The Tissue-Type Plasminogen Activator Story

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/atvbaha.108.179655
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Human Visceral Adipose Tissue and the Plasminogen Activator Inhibitor Type 1

International Journal of Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2007English

4766075 Human Tissue Plasminogen Activator

Biotechnology Advances
Applied MicrobiologyBiotechnologyBioengineering
1989English

Tissue-Type Plasminogen Activator: A Role for O-Linked Fucose.

Journal of Clinical Investigation
Medicine
1994English

Role of Tissue-Type Plasminogen Activator in Remodeling of the Ductus Arteriosus

Circulation Reports
2020English

Tissue Plasminogen Activator Therapy for the Eye

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Novel Actions of Tissue-Type Plasminogen Activator in Chronic Kidney Disease

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2008English

Highly Stable Plasminogen Activator Inhibitor Type One (VLHL PAI-1) Protects Fibrin Clots From Tissue Plasminogen Activator-Mediated Fibrinolysis

International Journal of Molecular Medicine
MedicineGenetics
2007English

Tissue-Type Plasminogen Activator Regulates P35-Mediated Cdk5 Activation in the Postsynaptic Terminal

Journal of Cell Science
Cell Biology
2019English

Maspin Binds to Urokinase-Type and Tissue-Type Plasminogen Activator Through Exosite-Exosite Interactions

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy